Ethyl 4,6-dichloropyrimidine-2-carboxylate

Catalog No.: 
ACQZHP818
CAS No.: 
56032-01-0
Molecular Formula: 
C7H6Cl2N2O2
Molecular Weight: 
221.04
Ethyl 4,6-dichloropyrimidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$795.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4,6-dichloropyrimidine-2-carboxylate
IUPAC Nameethyl 4,6-dichloropyrimidine-2-carboxylate
MDL No.MFCD13195087
Molecular FormulaC7H6Cl2N2O2
Molecular Weight221.04
SMILESO=C(C1=NC(Cl)=CC(Cl)=N1)OCC
InChI KeyKRCJVOFXNWPEKL-UHFFFAOYSA-N
SynonymEthyl 4,6-dichloropyriMidine-2-carboxylate;2-Pyrimidinecarboxylic acid, 4,6-dichloro-, ethyl ester;Ethyl 4,6-dichloro-2-pyrimidinecarboxylate
CAS No.56032-01-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQZHP818 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRFOC571 route compound structure diagram
    ACRFOC571684220-30-2In Stock
  4. Then
  5. ACQZHP818 route product structure diagram
    ACQZHP81856032-01-0
Inquiry

2. ACQZHP818 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACRFOC571 route compound structure diagram
    ACRFOC571684220-30-2In Stock
  4. Then
  5. ACQZHP818 route product structure diagram
    ACQZHP81856032-01-0
Inquiry

3. ACQZHP818 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQZHP818 route product structure diagram
    ACQZHP81856032-01-0
Inquiry

Comments (0)